Ergo Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
- Revenue Growth 85.76%
- Profit Growth 67.75%
- Ebitda 99.80%
- Net Worth -3.56%
- Total Assets -2.21%
About Ergo Healthcare
Ergo Healthcare Private Limited (EHPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 June 2012 and has a history of 12 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.20 M.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33110MH2012PTC232064
-
Company No.
232064
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jun 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Ergo Healthcare Private Limited offer?
Ergo Healthcare Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Implant Kit, Dental Equipment.
Who are the key members and board of directors at Ergo Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Bhat
|
Director | 03-Dec-2012 | Current |
|
Rumi Patel
|
Director | 03-Dec-2012 | Current |
Financial Performance of Ergo Healthcare.
Ergo Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 85.76% increase. The company also saw a substantial improvement in profitability, with a 67.75% increase in profit. The company's net worth dipped by a decrease of 3.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ergo Healthcare?
In 2019, Ergo Healthcare had a promoter holding of 45.00% and a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Apr 2013 | Canara Bank | ₹1.20 M | Open |
How Many Employees Work at Ergo Healthcare?
Unlock and access historical data on people associated with Ergo Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ergo Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ergo Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
